CONSTELLATION BRANDS Earnings Preview: Recent $STZ Insider Trading, Hedge Fund Activity, and More

Constellation Brands ($STZ) is poised to report Q1 earnings on July 1st, with analysts expecting $2.58 billion in revenue and $3.43 EPS. Ahead of this, institutional investors have shown significant, albeit mixed, repositioning, with major additions by Berkshire Hathaway and FMR LLC alongside substantial reductions by others like Morgan Stanley. Wall Street analysts maintain a strong bullish outlook, with six 'Buy' or 'Overweight' ratings and a median price target of $205.0, underscoring positive sentiment despite minor mixed insider and congressional trading activity.

Analysis

Constellation Brands ($STZ) is approaching its July 1st earnings release with significant crosscurrents in investor positioning. While Wall Street analysts project revenue of approximately $2.58 billion and an EPS of $3.43, institutional holdings data from the most recent quarter reveals a sharp divergence of opinion. Several major institutions initiated or significantly increased their stakes, led by a new ~$1.17 billion position by Berkshire Hathaway (+113.5%) and substantial additions from FMR LLC and Capital World Investors. Conversely, Morgan Stanley liquidated a large portion of its holdings, selling ~$870 million, and nearly twice as many institutions (927) reduced their positions as those that added (483). This institutional debate contrasts sharply with a uniformly bullish outlook from Wall Street analysts, where six firms have issued 'Buy' or 'Overweight' ratings in recent months with no 'Sell' ratings recorded. This consensus is anchored by a median price target of $205.0. Other signals, such as insider and congressional trading, have been mixed and of low monetary value, suggesting they are secondary to the primary conflict between institutional flows and analyst conviction.

Key Decisions for Investors

• Given the significant divergence between major institutional buyers like Berkshire Hathaway and sellers like Morgan Stanley, the upcoming July 1st earnings report is a critical catalyst that could validate one side of the debate.
• The uniformly bullish sentiment from Wall Street, with six recent 'Buy' or 'Overweight' ratings and a median price target of $205.0, provides a strong basis for a positive thesis, should earnings meet or exceed expectations.
• Investors should treat the high number of institutions reducing their positions as a key risk factor and consider waiting for post-earnings clarity on fundamentals and guidance before committing significant new capital.
• The mixed and low-volume insider and congressional trading activity appears to be non-material and should not be a primary driver of an investment decision for STZ.